US 8815511
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted A61KA61K38/02A61K38/16
Quick answer
US patent 8815511 (Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/02, A61K38/16, A61K45/06, A61P